Boudewijn Gunning

3.0k total citations · 1 hit paper
23 papers, 1.3k citations indexed

About

Boudewijn Gunning is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Boudewijn Gunning has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Psychiatry and Mental health, 9 papers in Pediatrics, Perinatology and Child Health and 8 papers in Pharmacology. Recurrent topics in Boudewijn Gunning's work include Epilepsy research and treatment (16 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Cannabis and Cannabinoid Research (7 papers). Boudewijn Gunning is often cited by papers focused on Epilepsy research and treatment (16 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Cannabis and Cannabinoid Research (7 papers). Boudewijn Gunning collaborates with scholars based in Netherlands, United Kingdom and Spain. Boudewijn Gunning's co-authors include Daniel Checketts, Pauly Ossenblok, Liesbeth Reneman, Gilles van Luijtelaar, Jan Booij, Wim van den Brink, Jaap van der Meere, Eduardo Dunayevich, Ben Schmand and António Gil‐Nagel and has published in prestigious journals such as Journal of Child Psychology and Psychiatry, Psychopharmacology and Epilepsia.

In The Last Decade

Boudewijn Gunning

23 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome

2020 192 citations Ian Miller, Ingrid E. Scheffer et al. JAMA Neurology profile →

Peers

Boudewijn Gunning

PMH

CMN

PHARM

PPCH

CN

Daniel Checketts United Kingdom

Samuel W. Boellner United States

Patricia L. Bruno United States

M F Poirier France

Frank Theisen Germany

H. Kolbe Germany

Lineke Zuurman Netherlands

S Gershon United States

Melissa J. Benson Australia

Post Rm United States

Daniel Checketts United Kingdom

Boudewijn Gunning

922 ×1.1

PMH

560 ×1.2

CMN

1.2k ×3.1

PHARM

369 ×1.2

PPCH

172 ×0.6

CN

Citations per year, relative to Boudewijn Gunning Boudewijn Gunning (= 1×) peers Daniel Checketts

Countries citing papers authored by Boudewijn Gunning

Since Specialization

Citations

This map shows the geographic impact of Boudewijn Gunning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boudewijn Gunning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boudewijn Gunning more than expected).

Fields of papers citing papers by Boudewijn Gunning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boudewijn Gunning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boudewijn Gunning. The network helps show where Boudewijn Gunning may publish in the future.

Co-authorship network of co-authors of Boudewijn Gunning

This figure shows the co-authorship network connecting the top 25 collaborators of Boudewijn Gunning. A scholar is included among the top collaborators of Boudewijn Gunning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boudewijn Gunning. Boudewijn Gunning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Sullivan, Joseph, Boudewijn Gunning, Muhammad Zafar, et al.. (2023). Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy. Epilepsy Research. 191. 107112–107112. 19 indexed citations

2.

Patel, Anup D., Maria Mazurkiewicz‐Bełdzińska, Richard Chin, et al.. (2021). Long‐term safety and efficacy of add‐on cannabidiol in patients with Lennox–Gastaut syndrome: Results of a long‐term open‐label extension trial. Epilepsia. 62(9). 2228–2239. 74 indexed citations

3.

Ben‐Menachem, Elinor, Boudewijn Gunning, Carmen Cabrera, et al.. (2020). A Phase II Randomized Trial to Explore the Potential for Pharmacokinetic Drug–Drug Interactions with Stiripentol or Valproate when Combined with Cannabidiol in Patients with Epilepsy. CNS Drugs. 34(6). 661–672. 37 indexed citations

4.

Gunning, Boudewijn, Maria Mazurkiewicz‐Bełdzińska, Richard Chin, et al.. (2020). Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials. Acta Neurologica Scandinavica. 143(2). 154–163. 32 indexed citations

5.

Miller, Ian, Ingrid E. Scheffer, Boudewijn Gunning, et al.. (2020). Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome. JAMA Neurology. 77(5). 613–613. 192 indexed citations breakdown →

6.

Miller, Ian, Ingrid E. Scheffer, Boudewijn Gunning, et al.. (2019). Cannabidiol (CBD; 10 And 20 MG/KG/Day) Significantly Reduces Convulsive Seizure Frequency In Children And Adolescents With Dravet Syndrome: Results Of A Dose-Ranging, Multi-Center, Randomised, Double-Blind, Placebo-Controlled Trial (GWPCARE2). Epilepsia. 60. 1 indexed citations

7.

Thiele, Elizabeth A., Eric D. Marsh, Maria Mazurkiewicz‐Bełdzińska, et al.. (2019). Cannabidiol in patients with Lennox‐Gastaut syndrome: Interim analysis of an open‐label extension study. Epilepsia. 60(3). 419–428. 103 indexed citations

8.

Lange, Iris, Boudewijn Gunning, Anja C. M. Sonsma, et al.. (2018). Outcomes and comorbidities of SCN1A-related seizure disorders. Epilepsy & Behavior. 90. 252–259. 31 indexed citations

9.

Lange, Iris, Boudewijn Gunning, Anja C. M. Sonsma, et al.. (2018). Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A‐related seizure phenotypes. Epilepsia. 59(6). 1154–1165. 97 indexed citations

10.

Lange, Iris, Marco J. Koudijs, Ruben van ‘t Slot, et al.. (2018). Mosaicism of de novo pathogenic SCN1A variants in epilepsy is a frequent phenomenon that correlates with variable phenotypes. Epilepsia. 59(3). 690–703. 43 indexed citations

11.

Arends, Johan, et al.. (2016). Value of re-interpretation of controversial EEGs in a tertiary epilepsy clinic. Clinical Neurophysiology. 128(4). 661–666. 5 indexed citations

12.

Verbeek, Nienke E., Merel Wassenaar, Jolien S. van Campen, et al.. (2015). Seizure precipitants in Dravet syndrome: What events and activities are specifically provocative compared with other epilepsies?. Epilepsy & Behavior. 47. 39–44. 29 indexed citations

13.

Ossenblok, Pauly, et al.. (2009). Onset and propagation of spike and slow wave discharges in human absence epilepsy: A MEG study. Epilepsia. 50(12). 2538–2548. 145 indexed citations

14.

Nicolai, Joost, Boudewijn Gunning, Piet Leroy, Berten Ceulemans, & Johan S.H. Vles. (2007). Acute hepatic injury in four children with Dravet syndrome: Valproic acid, topiramate or acetaminophen?. Seizure. 17(1). 92–97. 5 indexed citations

15.

Reneman, Liesbeth, Jan Booij, Jules Lavalaye, et al.. (2001). Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]β-CIT SPECT study – preliminary report. Psychopharmacology. 159(3). 335–340. 52 indexed citations

16.

Reneman, Liesbeth, Jan Booij, Ben Schmand, Wim van den Brink, & Boudewijn Gunning. (2000). Memory disturbances in ”Ecstasy" users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology. 148(3). 322–324. 146 indexed citations

17.

Meere, Jaap van der, et al.. (1999). The Effect of Methylphenidate and Clonidine on Response Inhibition and State Regulation in Children with ADHD. Journal of Child Psychology and Psychiatry. 40(2). 291–298. 59 indexed citations

18.

Meere, Jaap van der, et al.. (1999). The Effect of Methylphenidate and Clonidine on Response Inhibition and State Regulation in Children with ADHD. Journal of Child Psychology and Psychiatry. 40(2). 291–298. 46 indexed citations

19.

Taylor, Eric, Joseph A. Sergeant, Manfred Döepfner, et al.. (1998). Clinical guidelines for hyperkinetic disorder. European Child & Adolescent Psychiatry. 7(4). 184–200. 101 indexed citations

20.

Gunning, Boudewijn. (1992). A Controlled Trial of Clonidine in Hyperkinetic Children. Data Archiving and Networked Services (DANS). 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact